Cannabinoid drugs and enhancement of endocannabinoid responses: Strategies for a wide array of disease states

Current Molecular Medicine

Volumn 6, Issue 6, 2006, Pages 677-684

  Karanian, David A ^a   Bahr, Ben A ^a  

^a UNIVERSITY OF CONNECTICUT   (United States)

Author keywords

Cannabinoid receptor agonists; CB1 receptor; Endocannabinoid system; FAAH; Neuroprotection

Indexed keywords

1 (2,4 DICHLOROPHENYL) 5 (4 IODOPHENYL) 4 METHYL N (1 PIPERIDYL) 1H PYRAZOLE 3 CARBOXAMIDE; 2 ARACHIDONOYLGLYCEROL; 2,3 DIHYDRO 5 METHYL 3 (MORPHOLINOMETHYL) 6 (1 NAPHTHOYL)PYRROLO[1,2,3 DE][1,4]BENZOXAZINE; 3 (2 HYDROXYMETHYLINDANYL 4 OXY)PHENYL 4,4,4 TRIFLUORO 1 SULFONATE; 4 (1,1 DIMETHYLHEPTYL) 1',2',3',4',5',6' HEXAHYDRO 2,3' DIHYDROXY 6' (3 HYDROXYPROPYL)BIPHENYL; ACYLGLYCEROL LIPASE; ANANDAMIDE; ANTICONVULSIVE AGENT; ANTINEOPLASTIC AGENT; BAY 387271; CANNABIDIOL; CANNABINOID; CANNABINOID 1 RECEPTOR; CANNABINOID 2 RECEPTOR; CANNABINOID RECEPTOR AGONIST; DRONABINOL; ENDOCANNABINOID; FATTY ACID AMIDASE; FOCAL ADHESION KINASE; METHANANDAMIDE; MITOGEN ACTIVATED PROTEIN KINASE; N (3 FURYLMETHYL)ARACHIDONAMIDE; N (3 FURYLMETHYL)ICOSA 5,8,11,14 TETRAENAMIDE; N (4 HYDROXY 2 METHYLPHENYL) 5,8,11,14 ICOSATETRAENAMIDE; N (4 HYDROXY 2 METHYLPHENYL)ARACHIDONAMIDE; N (4 HYDROXYPHENYL)ARACHIDONAMIDE; NEUROPROTECTIVE AGENT; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; RIMONABANT; UNCLASSIFIED DRUG;

ADDICTION; ALLERGIC DISEASE; BRAIN INJURY; BRAIN ISCHEMIA; CANCER; CELL SURVIVAL; CHRONIC PAIN; CLINICAL TRIAL; DEGENERATIVE DISEASE; DRUG INDICATION; DRUG INDUCED DISEASE; DRUG RECEPTOR BINDING; EATING DISORDER; EXCITOTOXICITY; GLAUCOMA; HUMAN; INFLAMMATORY DISEASE; INTERNALIZATION; MULTIPLE SCLEROSIS; NAUSEA; NEUROTOXICITY; NONHUMAN; PROTEIN HYDROLYSIS; PSYCHOSIS; REVIEW; SCHIZOPHRENIA; SEIZURE; SIGNAL TRANSDUCTION; WASTING SYNDROME;

ANIMALS; CANNABINOIDS; ENDOCANNABINOIDS; HIPPOCAMPUS; HUMANS; MICE; MODELS, BIOLOGICAL; NEURODEGENERATIVE DISEASES; NEUROTOXINS; RECEPTORS, CANNABINOID; SIGNAL TRANSDUCTION;

EID: 33748589455     PISSN: 15665240     EISSN: None     Source Type: Journal    
DOI: 10.2174/156652406778194991     Document Type: Review

References (127)

1. Herkenham, M., Lynn, A.B., Little, M.D., Johnson, M.R., Melvin, L.S., de Costa, B.R. and Rice, KC. (1990) Proc. Natl. Acad. Sci. USA, 87, 1932-1936.
2. Gatley, S.J., Gifford, A.N., Volkow, N.D., Lan, R. and Makriyannis, A. (1996) Eur. J. Pharmacol., 307, 331-338.
3. Marsicano, G. and Lutz, B. (1999) Eur. J. Neurosci., 12, 4213-4225.
4. Makriyannis, A., Mechoulam, R. and Piomelli, D. (2005) Neuropharmacology, 48, 1068-1071.
5. Di Marzo, V. and Matias, I. (2005) Nature Neurosci., 8, 585-589.
6. Bahr, B.A., Karanian, D.A., Makanji, S.S., Makriyannis, A. (2006) Exp. Opin., 15, 351-365.
7. Munro, S., Thomas, K.L. and Abu-Shaar, M. (1993) Nature, 365, 12-13.
8. Griffin, G., Wray, E.J., Tao, Q., McAllister, S.D., Rorrer, W.K., Aung, M.M., Martin, B.R., Abood, M.E. (1999) Eur. J. Pharmacol., 377, 117-125.
9. Benito, C., Nunez, E., Tolon, R.M., Carrier, E.J., Rabano, A., Hillard, C.J. and Romero, J. (2003) J. Neurosci., 23, 11136-11141.
10. Benito, C., Kim, W.K., Chavarria, I., Hillard, C.J., Mackie, K., Tolon, R.M., Williams, K. and Romero, J.A. (2005) J. Neurosci., 25, 2530-2536.
11. Van Sickle, M.D., Duncan, M., Kingsley, P.J., Mouihate, A., Urbani, P., Mackie, K., Stella, N., Makriyannis, A., Piomelli, D., Davison, J.S., Marnett, L.J., Di Marzo, V., Pittman, Q.J., Patel, K.D. and Sharkey, K.A. (2005) Science, 310, 329-332.
12. Tsou, K., Mackie, K., Sanudo-Pena, M.C. and Walker, J.M. (1999) Neuroscience, 93, 969-975.
13. Tsou, K., Brown, S., Sanudo-Pena, M.C., Mackie, K. and Walker, J.M. (1998) Neuroscience, 83, 393-411.
14. Hampson, R.E. and Deadwyler, S.A. (1998) Neurobiol. Dis. Exp. Neurol. B., 5, 474-482.
15. Hampson, R.E. and Deadwyler, S.A. (2000) J. Neurosci., 20, 8932-8942.
16. Shen, M. and Thayer, S.A. (1998) Mol. Pharmacol., 54, 459-462.
17. Marsicano, G., Goodenough, S., Monory, K., Hermann, H., Eder, M., Cannich, A., Azad, SC., Cascio, M.G., Gutierrez, S.O., van der Stelt, M., Lopez-Rodriguez, M.L., Casonova, E., Schutz, G., Zieglgansberger, W., Di Marzo, V., Behl, C. and Lutz, B. (2003) Science, 302, 84-88.
18. Karanian, D.A., Brown, Q.B., Makriyannis, A., Kosten, T.A. and Bahr, B.A. (2005) J. Neurosci., 25, 7813-7820.
19. Stella, N., Schweitzer, P. and Piomelli, D. (1997) Nature, 388, 773-778.
20. Devane, W.A., Hanus, L., Breuer, A., Pertwee, R.G., Stevenson, L.A., Griffin, G., Gibson, D., Mandelbaum, A., Etinger, A. and Mechoulam, R. (1992) Science, 258, 1946-1949.
21. Felder, C.C., Joyce, K.E., Briley, E.M., Mansouri, J., Mackie, K., Blond, O., Lai, Y., Ma, A.L. and Mitchell, R.L. (1995) Mol. Pharmacol., 48, 443-450.
22. Mechoulam, R., Ben-Shabat, S., Hanus, L., Ligumsky, M., Kaminski, N.E., Schatz, A.R., Gopher, A., Almog, S., Martin, B.R. and Compton, D.R. (1995) Biochem. Pharmacol., 50, 83-90.
23. Mechoulam, R., Fride, E. and Di Marzo, V. (1998) Eur. J. Pharmacol., 359, 1-18.
24. Hillard, CJ. (2000) Prostaglandins Other Lipid Mediat., 61, 3-18.
25. Bisogno, T., Berrendero, F., Ambrosino, G., Cebeira, M., Ramos, J.A., Fernandez-Ruiz, J.J. and Di Marzo, V. (1999) Biochem. Biophys. Res. Commun., 256, 377-380.
26. Bisogno, T., Sepe, N., Melck, D., Maurelli, S., De Petrocellis, L. and Di Marzo, V. (1997) Biochem. J., 322, 671-677.
27. Piomelli, D., Beltramo, M., Glasnapp, S., Lin, S.Y., Goutopoulos, A., Xie, X.Q. and Makriyannisl, A. (1999) Proc. Natl. Acad. Sci. USA, 96, 5802-5807.
28. Baker, D., Pryce, G., Croxford, J.L., Brown, P., Pertwee, R.G., Makriyannis, A., Khanolkar, A., Layward, L., Fezza, F., Bisogno, T. and Di Marzo, V. (2001) FASEB J., 12, 300-302.
29. Hansen, H.H., Schmid, P.C. and Bittigau, P. (2001) J. Neurochem., 78, 1415-1427.
30. Panikashvili, D., Simenidou, C., Ben-Shabat, S., Hanus, L., Breuer, A., Mechoulam, R. and Shoami, E. (2001) Nature, 413, 527-531.
31. Maccarrone, M., Gubellini, P., Bari, M., Picconi, B., Battista, N., Centonze, D., Bernardi, G., Finazzi-Agro, A. and Calabresi, P. (2003) J. Neurochem., 85, 1018-1025.
32. Howlett A.C. and Mukhopadhyay, S. (2000) Chem. Phys. Lipids. 108, 53-70.
33. Breivogel, C.S., Griffin, G., Di-Marzo, V. and Martin, B.R. (2001) Mol. Pharmacol., 60, 155-163.
34. Derkinderen, P., Valjent, E., Toutant, M., Corvol, J.C., Enslen, H., Ledent, C., Trzaskos, J., Caboche, J., Girault, J.A. (2003) J. Neurosci., 23, 2371-2382.
35. Karanian, D.A., Brown, Q.B., Makriyannis, A. and Bahr, B.A. (2005) Eur. J. Pharmacol., 508, 47-56.
36. Di Marzo, V., Fontana, A., Cadas, H., Schinelli, S., Cimino, G., Schwartz, and J.C., Piomelli, D. (1994) Nature, 372, 686-691.
37. Beltramo, M., Stella. N., Calignano, A., Lin, S.Y., Makrivannis, A. and Piomelli, D. (1997) Science, 277, 1094-1097.
38. Fegley, D., Kathuria, S., Mercier, R., Li, C., Goutopoulos, A., Makriyannis, A. and Piomelli, D. (2004) Proc. Natl. Acad. Sci. USA, 101, 8756-8761.
39. Cravatt, B.F., Giang, D.K., Mayfield, S.P., Boger, D.L., Lerner, R.A. and Gilula, N.B. (1996) Nature, 384, 83-87.
40. Cravatt, B.F., Demarest, K., Patricelli, M.P., Bracey, M.H., Giang, D.K., Martin, B.R. and Lichtman, A.H. (2001) Proc. Natl. Aced. Sci. USA, 98, 9371-9376.
41. Egertova, M., Cravatt, B.F., Elphick, M.R. (2003) Neuroscience, 119, 481-496.
42. Morozov, Y.M., Ben-Ari, Y. and Freund, T.F. (2004) Eur. J. Neurosci., 20, 459-466.
43. Beltramo, M. and Piomelli, D. (2000) Neuroreport., 11, 1231-1235.
44. Bisogno, T., MacCarrone, M., De Petrocellis, L., Jarrahian, A., Finazzi-Agro, A., Hillard, C. and Di Marzo, V. (2001) Eur. J. Biochem., 268, 1982-1989.
45. Di Marzo, V., Bisogno, T., De Petrocellis, L., Melck, D., Orlando, P., Wagner, J.A. and Kunos, G. (1999) Eur. J. Biochem., 264, 258-267.
46. Dinh, T.P., Carpenter, D., Leslie, F.M., Freund, T.F, Katona, I., Sensi, S.L., Kathuria, S. and Piomelli, D. (2002) Proc. Natl. Acad. Sci. USA, 99, 10819-10824.
47. Dinh, T.P., Kathuria, S. and Piomelli, D. (2004) Mol. Pharmacol., 66, 1260-1264.
48. Giuffrida, A., Rodriguez de Fonseca, F., Nava, F., Loubet-Lescoulie, P., Piomelli, D. (2000) Eur. J. Pharmacol., 408, 161-168.
49. Hajos, N., Kathuria, S., Dinh, T., Piomelli, D., Freund, T.F. (2004) Eur. J. Neurosci., 19, 2991-2996.
50. Kathuria, S., Gaetani, S., Fegley, D., Valino, F., Duranti, A., Tontini, A., Mor, M., Tarzia, G., La Rana, G., Calignano, A., Giustino, A., Tattoli, M,. Palmery, M., Cuomo, V. and Piomelli, D. (2003) Nat. Med., 9, 76-81.
51. Makara, J.K., Mor, M., Fegley, D., Szabo, S.I., Kathuria, S., Astarita, G., Duranti, A., Tontini, A., Tarzia, G., Rivara, S., Freund, T.F. and Piomelli, D. (2005) Nat. Neurosci., 8, 1139-1141.
52. Abadji, V., Lin, S., Taha, G., Griffin G., Stevenson, L.A., Pertwee, R.G. and Makriyannis, A., (1994) J. Med Chem., 37, 1889-1893.
53. Jarbe, T.U., Lamb, R.J., Lin, S. and Makriyannis, A. (2001) Psychopharmacology, 4, 369-380.
54. Goutopoulos, A., Fan, P., Khanolkar, A.D., Xie, X.Q., Lin, S. and Makriyannis, A. (2001) Bioorg. Med. Chem., 7, 1673-1684.
55. Gelfand, E.V., Cannon, C.P. (2006) Exp. Opin. Investig. Drugs, 15, 307-315.
56. Despres, J.P., Golay, A., Sjostrom, L. (2005) N. Engl. J. Med., 353, 2121-2134.
57. Cox, S.L. (2005) Drugs Today (Barc.), 41, 499-508.
58. Sinor, A.D., Irvin, S.M. and Greenberg, D.A. (2000) Neurosci. Lett., 278, 137-160.
59. Louw, D.F., Yang, F.W. and Sutherland, G.R. (2000) Brain Res., 857, 183-187.
60. Leker, R.R., Gai, N., Mechoulam, R. and Ovadia, H. (2003) Stroke, 34, 2000-2006.
61. Nagayama, T., Sinor, A.D., Simon, R.P., Chen, J., Graham, S.H., Jin, K. and Greenberg, D.A. (1999) J. Neurosci., 19, 2987-2995.
62. Parmentier-Batteur, S., Jin, K., Mao, X.O., Xie, L. and Greenberg, D.A. (2002) J. Neurosci., 22, 9771-9775.
63. Van der Stelt, M., Veldhuis, W.B., Bar, P.R., Veldink, G.A., Vliegenthart, J.F. and Nicolay, K. (2001) J. Neurosci., 21, 6475-6479.
64. El-Remessy, A.B., Khalil, I.E., Matragoon, S., Abou-Mohamed, G., Tsai, N.J., Roon, P., Caldwell, R.B., Caldwell, R.W., Green, K. and Liou, G.I. (2003) Am. J. Pathol., 163, 1997-2008.
65. Bisogno, T., Hanus, L., De Petrocellis, L., Tchilibon, S., Ponde, D.E., Brandi, I., Moriello, A.S., Davis, J.B., Mechoulam, R., Di Marzo, V. (2001) Br. J. Pharmacol. 134, 845-852.
66. Long, L.E., Malone, D.T., Taylor, D.A. (2006) Neuropsychopharmacology, 31, 795-803.
67. Di Marzo, V., Blumberg, P.M., Szallasi, A. (2002) Curr. Opin. Neurobiol. 12, 372-379.
68. Pertwee, R.G. (2005) Handb. Exp. Pharmacol. 168, 1-51.
69. Wallace, M.J., Martin, B.R. and DeLorenzo, R.J. (2002) Eur. J. Pharmacol. 452, 295-301.
70. Wallace, M.J., Blair, R.E., Falenski, K.W., Martin, B.R. and DeLorenzo, R.J. (2003) J. Pharmacol. Exp. Ther., 307, 129-137.
71. Khaspekov, L.G., Brenz Verca, M.S., Frumkina, L.E., Hermann, H., Marsicano, G. and Lutz, B. (2004) Eur. J. Neurosci., 19, 1691-1698.
72. Mauler, F., Hinz, V., Augstein, K.H., Fassbender, M. and Horvath, E. (2003) Brain Res., 1, 99-111.
73. Iuvone, T., Esposito, G., Esposito, R., Santamaria, R., Di Rosa, M., Izzo, A.A. (2004) J. Neurochem., 89, 131-141.
74. Ramirez, B.G., Blazquez, C., Gomez del Pulgar, T., Guzman, M. and de Ceballos, M.L. (2005) J. Neuroscie 258, 1904-1913.
75. Lastres-Becker, I., Molina-Holgado, F., Ramos, J.A., Mechoulam, R. and Fernandez-Ruiz, J. (2005) Neurobiol. Dis., 19, 96-107.
76. Fernandez-Espejo, E., Caraballo, I., Rodriguez de Fonseca, F., Ferrer, B., Banoua, F.E., Flores, J.A., Galan-Rodriguez, B. (2004) Neuropsychopharmacology, 29, 1134-1142.
77. Raman, C., McAllister, S.D., Rizvi, G., Patel, S.G., Moore, D.H. and Abood, M.E. (2004) Amyotroph. Lateral Scler. Other Motor Neuron Disord., 5, 33-39.
78. Weydt, P., Hong, S., Witting, A., Moller, T., Stella, N. and Kliot, M. (2005) Amyotroph. Lateral Scler. Other Motor Neuron Disord., 6, 182-184.
79. Lastres-Becker, I., Hansen, H.H., Berrendero, F., De Miguel, R., Perez-Rosado, A., Manzanares, J., Ramos, J.A. and Fernandez-Ruiz, J. (2002) Synapse, 44, 23-35.
80. De Lago, E., Fernandez-Ruiz, J., Ortega-Gutierrez, S., Cabranes, A., Pryce, G., Baker, D., Lopez-Rodriguez, M. and Ramos, J.A. (2006) Eur. Neuropsychopharmacol., 16, 7-18.
81. Baker, D., Pryce, G., Croxford, J.L., Brown, P., Pertwee, R.G., Huffman, J.W. and Layward, L. (2000) Nature, 404, 84-87.
82. Mestre, L., Correa, F., Arevalo-Martin, A., Molina-Holgado, E., Valenti, M., Ortar, G., Di Marzo, V. and Guaza, C. (2005) J. Neurochem., 6, 1327-1339.
83. Bifulco, M. and Di Marzo, V. (2002) Nat. Med., 8, 547-550.
84. Velasco, G., Galve-Roperh, I., Sanchez, C., Blazquez, C. and Guzman, M. (2004) Neuropharmacology, 47, 315-323.
85. Galve-Roperh, I., Sanchez, C., Cortes, M.L., del Pulgar, T.G., Izquierdo, M. and Guzman, M. (2000) Nat. Med., 6, 313-319.
86. Bifulco, M., Laezza, C., Valenti, M., Ligresti, A., Portella, G. and Di Marzo, V. (2004) FASEB J., 18, 1606-1608.
87. Parker, L.A., Kwiatkowska, M., Burton, P. and Mechoulam, R. (2004) Psychopharmacology, 171, 156-161.
88. Tramer, M.R., Carroll, D., Campbell, F.A., Reynolds, D.J., Moore, R.A. and McQuay, H.J. (2001) BMJ., 323, 16-21.
89. Parker, LA., Kwiatkowska, M. and Mechoulam, R. (2006) Physiol. Behav., 87, 66-71.
90. Koch, J.E. (2001) Pharmacol. Biolchem. Behav., 68, 539-543.
91. Bernadette, H. (2005) Drug Discov. Today, 7, 459-62.
92. Cota, D., Marsicano, G., Lutz, B., Vicennati, V., Stalla, G.K., Pasquali, R. and Pagotto, U. (2003) Int. J. Obes. Relat. Metab. Disord., 27, 289-301.
93. McLaughlin, P.J., Winston, K.M., Limebeer, C.L., Parker, L.A., Makriyannis, A., Salamone, J.D. (2005) Psychopharmacology, 180, 286-293.
94. McLaughlin, P.J., Qian, L., Wood, J.T., Wisniecki, A., Winston, K.M., Swezey, L.A., Ishiwari, K., Betz, A.J., Pandarinathan, L., Xu, W., Makriyannis, A., Salamone, J.D. (2006) Pharmacol. Biochem. Behav., 83, 396-402.
95. Grotenhermen, F. (2005) Curr. Drug Targets CNS Neurol. Disord., 4, 507-530.
96. Costa, B., Colleoni, M., Conti, S., Parolaro, D., Franke, C., Trovato, A.E. and Giagnoni, G. (2004) Naunyn Schmiedebergs Arch. Pharmacol., 369, 294-299.
97. Sagar, D.R., Kelly, S., Millns, P.J., O'Shaughnessey, C.T., Kendall, D.A. and Chapman, V. (2005) Eur. J. Neurosci., 22, 371-379.
98. Cravatt, B.F. and Lichtman, A.H. (2004) J. Neurobiol., 1, 149-160.
99. Hohmann, A.G., Suplita, R.L., Bolton, N.M., Neely, M.H., Fegley, D., Mangieri, R., Krey, J.F., Walker, J.M., Holmes, P.V., Crystal, J.D., Duranti, A., Tontini, A., Mor, M., Tarzia, G., Piomelli, D. (2005) Nature, 435, 1108-1112.
100. Giuffrida A., Leweke, F.M., Gerth, C.W., Schreiber, D., Koethe, D., Faulhaber, J., Klosterkotter, J. and Piomelli, D. (2004) Neuropsychopharmacology 29, 2108-2114.
101. D'Souza, D.C, Perry, E.. MacDougall, L., Ammerman, Y., Cooper, T., Wu, Y.T., Braley, G., Gueorguieva, R. and Krystal, J.H. (2004) Neuropsychopharmacology, 8, 1558-1572.
102. Long, L.E., Malone, D.T. and Taylor, D.A. (2006) Neuropsychopharmacology, 31, 795-803.
103. Bouaboula, M., Poinot-Chazel, C., Bourrie, B., Canat, X., Calandra, B. Rinaldi-Carmona, M., Le Fur, G. and Casellas, P. (1995) Biochem. J., 312, 637-641.
104. Derkinderen, P., Toutant, M., Burgaya, F., Le Bert, M., Siciliano, J.C., de Franciscis, V., Gelman, M. and Girault, J.A. (1996) Science, 273, 1719-1722.
105. Galve-Roperh, I., Rueda, D., Gomez del Pulgar, T., Velasco, G., Guzman, M. (2002) Mol. Pharmacol., 62, 1385-1392.
106. Mackie, K. and Hille, B. (1992) Proc. Natl. Acad. Sci. USA, 89, 3825-3829.
107. Deadwyler, S.A., Hampson, R.E., Bennett, B.A., Edwards, T.A., Mu, J., Pacheco, M.A., Ward, S.J. and Childers, S.R. (1993) Recept. Channels, 2, 121-134.
108. Childers, S.R., Pacheco, M.A., Bennett, B.A., Edwards, T.A., Hampson, R.E., Mu, J. and Deadwyler, S.A. (1993) Biochem. Soc. Symp., 59, 27-50.
109. Twitchell, W., Brown, S. and Mackie, K. (1997) J. Neurophysiol., 78, 43-50.
110. Piomelli, D. (2003) Nat. Rev. Neurosci., 11, 873-884.
111. Kobayashi, Y., Arai, S., Waku, K. and Sugiura, T. (2001) J. Biochem., 129, 665-669.
112. Valjent, E., Pages, C., Rogard, M., Besson, M.J., Maldonado, R. and Caboche, J. (2001) Eur. J. Neurosci., 14, 342-352.
113. Han, B.H. and Holtzman, D.M. (2000) J. Neurosci., 20, 5775-5781.
114. Bonni, A., Brunet, A., West, A.E., Datta, S.R., Takasu, M.A., Greenberg, M.E. (1999) Science, 286, 1358-1362.
115. Bahr, B.A., Bendiske, J., Brown, Q.B., Munirathinam, S., Caba, E., Rudin, M., Urwyler, S., Sauter, A., Rogers, G. (2002) Exp. Neurol., 174, 37-47.
116. Derkinderen, P., Ledent, C., Parmentier, M. and Girault, J.A. (2001) J. Neurochem., 77, 957-960.
117. Chen. J., Errico, S.L. and Freed, W.J. (2005) Neurosci. Lett., 389, 99-103.
118. Derkinderen, P., Toutant, M., Kadare, G., Ledent, C., Parmentier, M. and Girault, J.A. (2001) J. Biol. Chem., 276, 38289-38296.
119. Gomez del Pulgar, T., Velasco, G. and Guzman, M. (2000) Biochem. J., 347, 369-373.
120. Molina-Holgado, E., Vela, J.M., Arevalo-Martin, A., Almazan, G., Molina-Holgado, F., Borrell, J. and Guaza, C. (2002) J. Neurosci., 22, 9742-9753.
121. Frisch, S.M., Vuori, K., Ruoslahti, E. and Chan-Hui, P.Y. (1996) J. Cell Biol., 134, 793-799.
122. Liu, X.W., Bernardo, M.M., Fridman, R. and Kim, H.R., (2003) J. Biol. Chem., 278, 40364-40372.
123. Shen, M., Piser, T.M., Seybold, V.S. and Thayer, S.A. (1996) J. Neurosci., 16, 4322-4334.
124. Gerdeman, G. and Lovinger, D. M. (2001) J. Neurophysiol., 85, 468-471.
125. Huang, C. C., Lo, S. W. and Hsu, K. S. (2001) J. Physiol., 532, 731-748.
126. Romero, J., Berrendero, F., Manzanares, J., Perez, A., Corchero, J., Fuentes, J.A., Fernandez-Ruiz, J.J. and Ramos, J.A. (1998) Synapse, 30, 298-308.
127. Sim-Selley, L.J. (2003) Crit. Rev. Neurobiol., 2, 91-119.